Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
Study sponsor: Oculis
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-03-27Actual
Enrollment · participants122Actual
Source updated2025-07-02Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.